Strata Critical Medical reported second quarter 2026 revenue of $72.5 million, a 60.7% increase year-over-year, driven by organic logistics growth and recent clinical acquisitions. The company posted a net loss from continuing operations of $(10.5) million, or $(0.12) per share, compared to a $(3.4) million loss in the prior year period. Adjusted EBITDA rose 219.8% to $7.9 million with a margin of 10.9%. Management updated full-year 2026 revenue guidance upward to $285-295 million and adjusted EBITDA guidance to $33-35 million, citing strong execution in its clinical services expansion. The company completed three bolt-on acquisitions during the quarter and signed an agreement to acquire Statline's Transplant Center Organ Placement customer relationships. Strata Critical Medical operates in the medical logistics and critical care staffing industry.